Trial intelligence / Profile preview

ATHOS Study: Telmisartan/HCTZ vs Amlodipine/HCTZ in Elderly Systolic Hypertension

NCT00240474Phase 4Completed

Sponsor
Boehringer Ingelheim
Start
Dec 2002
Primary completion
Mar 2004
Modality
Small Molecules
Countries
10
01

Overview

A Phase 4 trial of telmisartan in isolated systolic hypertension (ISH), sponsored by Boehringer Ingelheim. Started Dec 2002; status: completed.

02

Drugs

telmisartan
03

Conditions

isolated systolic hypertension (ISH)

Beyond the preview

Go deeper on NCT00240474.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00240474.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call